Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Azzak34on May 01, 2024 11:16am
91 Views
Post# 36017337

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:“Conference call to discuss “A” corporate update”….

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:“Conference call to discuss “A” corporate update”….You don't get to decide how people feel about it Buckster. Aren't you forever yammering about free speech and the "pumpers" not accepting your low IQ l, drivel on the daily. 

Webmd helps to diagnose illness. We already know the illness idiot, it's cancer. Pela is improving outcomes and prolonging lives. You're consistent laissez-faire attitude to this fact is repugnant. 

Regardless if you're here for the money or here for the potential Pela has, it doesn't matter. Yep, it's taken longer than it should but ONCY can use my money to save, improve and prolong lives!!! And for my trouble and time I'll a make a very, very healthy ROI. 
<< Previous
Bullboard Posts
Next >>